FDA daily

FDA daily for Monday, October 5, 2026

In this issue: 16 approvals, 8 device recalls, 17 device decisions and 5 label changes.

Drug and biologic approvals

FDA date:

On Mon, Sep 28 FDA approved 3 new applications (1 brand or biologic, 2 generic) and 13 supplements to existing ones.

Browse drug and biologic approvals in FDA data →

Device recalls

FDA date:

FDA posted 8 device recalls from 2 firms on Mon, Sep 28.

Browse device recalls in FDA data →

Device clearances and approvals

FDA date:

FDA decided 11 510(k)s and 6 PMA decisions on Mon, Sep 21.

Browse device clearances and approvals in FDA data →

Label updates

FDA date:

5 drug labels took effect on Mon, Sep 21.

Browse label updates in FDA data →

FDA did not answer for Food and supplement recalls, Drug shortages, Drug recalls while this issue was written; those sections will fill in on a later visit.

How the FDA daily is written

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.

Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.

Read FDA's day. Stock your practice.

Join free with your NPI: wholesale pricing from verified vendors, with the FDA and state rules for each category one click away.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.